Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLPG1205 in a UVB sunburn pain model in healthy male volunteers
NL-OMON44450Active, not recruiting
- Sponsor
- Galapagos NV
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of GLPG1205 in pain, nociceptive pain and None (2 arms), sponsored by Galapagos NV. Primary endpoint: Heat pain tolerance in preventative setting. Started Aug 2017; status: active, not recruiting.
02
Drugs
GLPG1205
03
Conditions
painnociceptive pain
Beyond the preview
Go deeper on NL-OMON44450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44450.